http://pharmexec.findpharma.com/pharmexec The publisher of Pharmaceutical Executive brings visitors PharmExec.com, which serves up a daily dose of news and features from the world of pharma business and marketing. 2009-07-03T01:20:49Z http://pharmexec.findpharma.com/pharmexec/News+Analysis/Abbott-to-Pay-167B-in-Patent-Suit/ArticleStandard/Article/detail/608192?ref=25 J&J emerged victorious in a patent suit claiming that the technology behind Abbott's blockbuster arthritis treatment Humira is too similar in design to J&J's Remicade. The cost to Abbott: $1.67 Billion. 2009-07-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/272009/608192null HTML http://pharmexec.findpharma.com/pharmexec/Web+Exclusives/Calculating-Risk/ArticleStandard/Article/detail/608138?ref=25 A risk-based approach to records and information management can be an integral part of the effort to reduce costs stemming from litigation. 2009-07-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/272009/608138null HTML http://pharmexec.findpharma.com/pharmexec/Europe/Finding-the-Perfect-Pharma-Match/ArticleStandard/Article/detail/607534?ref=25 In the wake of news of AZ and Merck's pioneering early stage cancer trial collaboration, Jacky Law looks at a new 'speed networking' platform which aims to help scientists and companies find their perfect 'research match.' 2009-06-30T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/272009/607534null HTML http://pharmexec.findpharma.com/pharmexec/Europe/New-EU-Committee-Leaves-Member-States-Out-In-The-C/ArticleStandard/Article/detail/605604?ref=25 Reflector explains why a new EU pharmacovigilance committee with room for 15 members, as opposed to 27, is re-opening some old European wounds. 2009-06-30T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605604null HTML http://pharmexec.findpharma.com/pharmexec/Europe/Pharmerging-Markets-And-The-New-World-Order/ArticleStandard/Article/detail/605606?ref=25 An IMS press briefing earlier this month dramatically predicted a new world ranking of global pharma markets by 2013. But there's more to just knowing where these markets are in order to succeed in the 'new world order.' 2009-06-30T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605606null HTML http://pharmexec.findpharma.com/pharmexec/Europe/GSK-Says-Asia-Pacific-Sales-Could-Double/ArticleStandard/Article/detail/607488?ref=25 30 June 2009 2009-06-30T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/272009/607488null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/European-Approval-for-UCBs-Cimzia/ArticleStandard/Article/detail/606771?ref=25 Europe's drug watchdog has recommended EU approval of UCB's rheumatoid arthritis drug Cimzia. 2009-06-26T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/606771null HTML http://pharmexec.findpharma.com/pharmexec/Web+Exclusives/Measuring-the-Value-of-KOL-Interactions/ArticleStandard/Article/detail/606150?ref=25 Thought leaders are a critical component of a pharmaceutical company?s professional marketing and medical strategies. But companies face a real challenge in creating, maintaining, and leveraging those relationships while safely navigating logistical issues and regulatory waters. 2009-06-24T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/606150null HTML http://pharmexec.findpharma.com/pharmexec/Europe/Too-much-market-focus-can-be-a-bad-thing/ArticleStandard/Article/detail/603822?ref=25 Dr Brian D. Smith looks at the value of management science to real-world pharmaceutical executives. 2009-06-23T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/603822null HTML http://pharmexec.findpharma.com/pharmexec/More-effective-connection-between-labs-scientists-/ArticleStandard/Article/detail/605243?ref=25 More effective connection between labs, scientists, and instruments with Waters® NuGenesis® SDMS. Streamline the capture, organization and accessibility of critical scientific data, accelerate product development and release. 2009-06-22T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605243null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/Genentech-ordered-to-halt-Rituxan-trials/ArticleStandard/Article/detail/604567?ref=25 18 June 2009 2009-06-18T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/604567null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/UCB-Teams-with-PatientsLikeMe-to-Learn-What-Patien/ArticleStandard/Article/detail/604391?ref=25 In an effort to learn as more about epilepsy sufferers, UCB will implement a social network that allows patients to communicate about their disease state and treatments. Think of it as one giant, online clinical trial. 2009-06-17T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/604391null HTML http://pharmexec.findpharma.com/pharmexec/June-TOC/ArticleStandard/Article/detail/604500?ref=25 June TOC 2009-06-17T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/604500null XML http://pharmexec.findpharma.com/pharmexec/Columns/Understanding-the-New-World-Order-of-Emerging-Mark/ArticleStandard/Article/detail/604394?ref=25 Pharma is wrestling to understand the emerging markets will be the engine of growth for future sales. 2009-06-17T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/604394null HTML http://pharmexec.findpharma.com/pharmexec/Strategy/Oscient-Pharmaceuticals-Lays-Off-180-Reps/ArticleStandard/Article/detail/604392?ref=25 Oscient trims 180 sales, marketing, and corporate jobs in the wake of patent expirations, generic competition. 2009-06-17T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/604392null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/Sudden-Deaths-and-ADHD-Meds-Not-Necessarily-Relate/ArticleStandard/Article/detail/604388?ref=25 Feds claim results of study comparing car crash deaths and children on ADHD drugs were not paramount to pulling kids off of ADHD treatments. 2009-06-17T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/604388null HTML http://pharmexec.findpharma.com/pharmexec/Europe/Knock-em-dead-with-your-website-press-centre/ArticleStandard/Article/detail/603135?ref=25 Tired of getting your press releases ignored? Joe Dysart shows you how, by tailoring your communications activities to Web 2.0, to court the media in ways that'll make you stand out. 2009-06-16T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603135null HTML http://pharmexec.findpharma.com/pharmexec/Europe/UK-biotech-situation-critical/ArticleStandard/Article/detail/603821?ref=25 As the UK biotech sector lurches further into financial crisis, BioIndustry Association (BIA) chairman Dr Clive Dix talks to Pharm Exec Europe's Stephanie Sutton about what the public and private sectors can do to help out. 2009-06-16T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/603821null HTML http://pharmexec.findpharma.com/pharmexec/Europe/IMIs-winner-and-losers/ArticleStandard/Article/detail/603820?ref=25 Reflector casts his eye over the 15 lucky winners of the recently-announced, €246 million round of Innovative Medicines Initiative (IMI) prizes. 2009-06-16T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/603820null HTML http://pharmexec.findpharma.com/pharmexec/Europe/NICE-recommends-Roches-leukaemia-drug/ArticleStandard/Article/detail/603823?ref=25 16 June 2009 2009-06-16T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/603823null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/GSK-battles-with-Russian-government/ArticleStandard/Article/detail/603595?ref=25 15 June 2009 2009-06-15T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/252009/603595null HTML http://pharmexec.findpharma.com/pharmexec/Europe/Schering-Plough-goes-Dutch/ArticleStandard/Article/detail/603391?ref=25 Schering-Plough has opened a new pharmaceutical manufacturing facility in Oss, the Netherlands. 2009-06-12T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603391null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/Merck-signs-discovery-deal-with-Xenon/ArticleStandard/Article/detail/603134?ref=25 12 June 2009 2009-06-12T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603134null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/WHO-Pushes-H1N1-Flu-to-Pandemic-State/ArticleStandard/Article/detail/603039?ref=25 The Word Health Organization just bumped the H1N1 influenza to pandemic alert phase 6 (the highest alert level), making it the first worldwide pandemic in 41 years. 2009-06-11T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603039null REMOTE http://pharmexec.findpharma.com/pharmexec/Europe+Events/ICSE-2009/ArticleStandard/Article/detail/602601?ref=25 13 October 2009 2009-06-10T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602601null HTML http://pharmexec.findpharma.com/pharmexec/Deals/GSK-Teams-with-Shenzhen-Neptunus-for-Chinese-Vacci/ArticleStandard/Article/detail/602668?ref=25 GlaxoSmithKline is expanding its influenza vaccine efforts through a joint R&D alliance with Shenzhen Neptunus. The goal: to tap the world’s biggest market and attempt to deliver flu shots to more than a billion people. 2009-06-10T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602668null HTML http://pharmexec.findpharma.com/pharmexec/News+Analysis/Wyeth-Winds-Up-With-New-Pristiq-Campaign/ArticleStandard/Article/detail/602670?ref=25 What do you do when you are introducing a new drug in an already crowded category? Wyeth queried depression sufferers to find out what they want to see in a drug ad before launching its new DTC campaign for Pristiq. 2009-06-10T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602670null HTML http://pharmexec.findpharma.com/pharmexec/Web+Exclusives/The-Ecology-of-Sampling-A-Call-to-Action/ArticleStandard/Article/detail/602530?ref=25 The pharmaceutical industry distributes more than $22 billion worth of medication samples in the US alone. It's time to revisit the issue of waste inherent in this marketing strategy. 2009-06-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602530null HTML http://pharmexec.findpharma.com/pharmexec/Europe/Opportunities-in-Vietnam/ArticleStandard/Article/detail/602440?ref=25 Jane Wan explains why 'the land of the ascending dragon' is one emerging pharma market that shouldn't be ignored. 2009-06-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602440null HTML http://pharmexec.findpharma.com/pharmexec/Web+Exclusives/Specialty-Pharma-Is-on-the-Move/ArticleStandard/Article/detail/602531?ref=25 One of the fastest growing segments in the industry, specialty pharmaceuticals are proving tough to track for most companies—creating critical gaps in the supply chain view that can distort strategic planning and impact competitive advantage. 2009-06-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602531null HTML http://pharmexec.findpharma.com/pharmexec/Europe/A-Cautionary-Tale-for-Executives/ArticleStandard/Article/detail/602420?ref=25 9 June 2009 2009-06-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602420null HTML http://pharmexec.findpharma.com/pharmexec/Pharm-Exec-Digest-Europe-Issue-archive/ArticleStandard/Article/detail/602412?ref=25 Issue archive for Pharm Exec Digest Europe 2009-06-09T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602412null HTML http://pharmexec.findpharma.com/pharmexec/Europe/Accelerate-your-therapeutic-protein-development-in/ArticleStandard/Article/detail/602149?ref=25 A 45-minute webinar on assay and system validation hosted by Marian Kelley, contributing author of DeSilva white paper, on behalf of Gyros AB. 2009-06-08T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/602149null HTML http://pharmexec.findpharma.com/pharmexec/Europe/Pfizer-completes-European-debt-offering/ArticleStandard/Article/detail/601617?ref=25 4 June 2009 2009-06-04T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601617null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Features/Reading-the-risk-radar/ArticleStandard/Article/detail/601616?ref=25 Following the publication of an Ernst & Young report highlighting the 10 biggest business risks facing life science companies, Pharm Exec Europe's Gerhard Symons speaks to Andrew Jones, a senior pharmaceutical analyst with the firm, about the value of introducing a 'risk radar' to your organisation. 2009-06-04T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601616null HTML http://pharmexec.findpharma.com/pharmexec/Europe+News/IMS-revises-predicted-global-pharma-growth-rate/ArticleStandard/Article/detail/601641?ref=25 New prediction reflects incremental pressure from economic crisis. 2009-06-04T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601641null HTML http://pharmexec.findpharma.com/pharmexec/Europe/Pharmaceutical-Execs-embrace-the-web/ArticleStandard/Article/detail/601618?ref=25 4 June 2009 2009-06-04T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601618null HTML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605665?ref=25 Several digital and interactive agencies, Kinect included, support the creation of appropriate FDA guidelines; however, not without the input of industry and other experts in areas of online marketing. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605665null XML http://pharmexec.findpharma.com/pharmexec/News+Analysis/ASCO-Roundup-Winners-Losers-and-Also-Rans/ArticleStandard/Article/detail/601559?ref=25 Due to pharma's voluntary moratorium on doling out totefuls of freebies and all the lattes you can swallow, thousands of docs, researchers, and reporters had only their sleep-deprived selves to carry from data dump to data dump at this week?s American Society of Clinical Oncology (ASCO) annual confab in Orlando, Florida. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601559null REMOTE http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605661?ref=25 At the end of the day you have tribes, some frequently not on the same "brand" page. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605661null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605657?ref=25 When economizing on agency spend, a key question needs to be answered: "Are you getting great value for your promotion?" 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605657null XML http://pharmexec.findpharma.com/pharmexec/Agency-Confidential-The-Scoopmdash-What-Your-Agenc/ArticleStandard/Article/detail/605663?ref=25 Pharma friendless on Facebook | DTC ad spending flat | Rate of healthcare marketing and advertising falls | Consumers chose food over meds | Some see light at tunnel's end 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605663null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605655?ref=25 It may not be sexy but now, more than ever, marketers need to look at their analytics. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605655null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605656?ref=25 In other industries, online marketing is used to cycle through options quickly and dynamically to reach an optimal solution. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605656null XML http://pharmexec.findpharma.com/pharmexec/News+Analysis/FDA-Launches-Transparency-Task-Force/ArticleStandard/Article/detail/601468?ref=25 The feds green lit a task force charged with easing the flow of communication between FDA, pharma companies, and the general public. While the team is being billed as a task force for transparency, it?s still unclear what is being revealed. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601468null HTML http://pharmexec.findpharma.com/pharmexec/Sales/Managing-the-Crisis-of-Marginalization/ArticleStandard/Article/detail/601469?ref=25 The key to managing the pharma sales force is to know when the customer wants good customer service, and when the customer needs good self-service. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601469null HTML http://pharmexec.findpharma.com/pharmexec/Deals/GSK-Signs-Deal-with-Concert-Pharma-to-the-Tune-of-/ArticleStandard/Article/detail/601466?ref=25 GlaxoSmithKline has entered into a collaboration deal with Concert to create drugs using deuterium—“heavy hydrogen”—that can be gathered from seawater and used to alter the way molecules perform in the body. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601466null HTML http://pharmexec.findpharma.com/pharmexec/Ive-Seen-The-Revolution-and-Its-Not-Working/ArticleStandard/Article/detail/605654?ref=25 Agency Insider Mark Chattaway infiltrates the world of online social media. And what does he find? Advertising on social networks is iffy at best; social media content is nearly all user-generated; and no one has figured out how to make real money out of it. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605654null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605664?ref=25 At a time when consumers are making decisions about filling a prescription and managing daily necessities, it becomes imperative that the industry approach to DTC reflects a "we are in it together" mindset. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605664null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605658?ref=25 It used to be that sacrificing one's own health was not an option. So now new responsibility has emerged for marketers. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605658null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605659?ref=25 What can change is what advertisers depict in many of the DTC ads for serious health-threatening conditions: the happy patient. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605659null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605662?ref=25 Pharma marketers must focus their efforts and resources on changing the behavior of professionals and concumsers. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605662null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605670?ref=25 One of most common mistakes that marketers make during a recession is to focus on cost rather than outcomes. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605670null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605653?ref=25 Few drugmakers have already been exploring Internet options beyond the "one-click" listings. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605653null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605660?ref=25 To help make the most out of a client's marketing spend, the preferred method is to utilize hard data, such as new patient starts, or prescription movement. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605660null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605666?ref=25 This latest action from the FDA has resulted in confusion, a need for counsel, and conjecture at what might be next. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605666null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605668?ref=25 Virtually all pharmaceutical manufacturers have robust policies to place needed medicines in the hands of those who cannot afford to pay for them. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605668null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605652?ref=25 Agency Confidential interrogated 21 executives at top healthcare agencies to find out the skinny on what is really happening with pharma marketing and advertising at this dire time for the industry. Here is the report. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605652null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605669?ref=25 Unless the brand is bleeding money, it's time to have a serious face-to-face discussion on staying the course 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605669null XML http://pharmexec.findpharma.com/pharmexec/Agency-Buzz/ArticleStandard/Article/detail/605667?ref=25 Research shows that budget cuts on advertising and marketing during times of recession have a long term negative impact. 2009-06-03T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605667null XML http://pharmexec.findpharma.com/pharmexec/Europe+Events/Patient-Compliance-2009/ArticleStandard/Article/detail/601093?ref=25 11 September 2009 2009-06-02T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601093null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Events/DigiPharm-Europe-2009/ArticleStandard/Article/detail/601095?ref=25 22 September 2009 2009-06-02T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601095null HTML http://pharmexec.findpharma.com/pharmexec/Driving-Product-Success-through-Patient-Adherence-/ArticleStandard/Article/detail/601345?ref=25 Patient Adherence and Compliance 2009-06-02T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601345null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Events/Working-through-drug-development/ArticleStandard/Article/detail/601091?ref=25 27 July 2009 2009-06-02T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601091null HTML http://pharmexec.findpharma.com/pharmexec/Europe+Events/Publication-strategy-amp-planning-summer-school/ArticleStandard/Article/detail/601090?ref=25 8 July 2009 2009-06-02T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/601090null HTML http://pharmexec.findpharma.com/pharmexec/Paulash-Mohsen-Pfizer/ArticleStandard/Article/detail/603291?ref=25 The Primary Care Business Unit at Pfizer has taken some major steps to respond to the needs of our customers. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603291null XML http://pharmexec.findpharma.com/pharmexec/Virginia-Carden-Carnahan-Vertex-Pharmaceuticals/ArticleStandard/Article/detail/603302?ref=25 I got my first taste of this industry as an intern at Schering-Plough's Managed Care group. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603302null XML http://pharmexec.findpharma.com/pharmexec/Hans-Bishop-Bayer-Healthcare/ArticleStandard/Article/detail/603279?ref=25 Pharma vet Hans Bishop readily admits to being ruthless in his career. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603279null XML http://pharmexec.findpharma.com/pharmexec/Jean-Marc-Huet-Bristol-Myers-Squibb/ArticleStandard/Article/detail/603298?ref=25 There is increasing importance of differentiation in the pharmaceutical industry, especially given the political, regulatory, and financial challenges we face. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603298null XML http://pharmexec.findpharma.com/pharmexec/Washington+Report/A-Bigger-Bolder-Agency/ArticleStandard/Article/detail/603294?ref=25 FDA is seeking more resources to support compliance and oversight. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603294null XML http://pharmexec.findpharma.com/pharmexec/Jennifer-Spear-Smith-Wyeth/ArticleStandard/Article/detail/603269?ref=25 Jennifer Spear Smith may be soft-spoken and petite, but she is loud, clear, and stands tall for one part of industry that she is clearly passionate about: continuing medical education (CME). 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603269null XML http://pharmexec.findpharma.com/pharmexec/Mohan-Bangalore-Wyeth/ArticleStandard/Article/detail/603276?ref=25 In 1993, my father died of lung cancer in India. During the years I watched him suffer with the disease, I decided that I would join pharmaceutical industry after my PhD to develop drugs (particularly aimed at treating cancer) and help improve the lives of patients. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603276null XML http://pharmexec.findpharma.com/pharmexec/Antonin-Tony-de-Fougerolles-Alnylam/ArticleStandard/Article/detail/603283?ref=25 As the fortunate recipient of a lot of medical care early in life, it was important for me to give back to the medical community. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603283null XML http://pharmexec.findpharma.com/pharmexec/Special+Reports/Emerging-Leaders-2009-The-Faces-of-Innovation/ArticleStandard/Article/detail/603281?ref=25 Our second annual Emerging Leadership Awards cast the spotlight on 27 young rising stars most notable for their dedication and contribution to the pharma industry. Here's a closer look at why. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603281/PE0609_ELA_thumbnail.jpg http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603281null XML http://pharmexec.findpharma.com/pharmexec/Frank-Karbe-Exelixis/ArticleStandard/Article/detail/603277?ref=25 Prior to joining Exelixis, I was an investment banker at Goldman Sachs, focusing on M&A and corporate finance. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603277null XML http://pharmexec.findpharma.com/pharmexec/Luca-Santarelli-Roche/ArticleStandard/Article/detail/603273?ref=25 Even in our crowd of underage overachievers, Luca Santarelli, MD, PhD, is a standout. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603273null XML http://pharmexec.findpharma.com/pharmexec/Don-Sawyer-Astrazeneca/ArticleStandard/Article/detail/603297?ref=25 In 1990, Don Sawyer entered industry like many others do: as a sales representative. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603297null XML http://pharmexec.findpharma.com/pharmexec/Elizabeth-Mutisya-Solvay-Pharmaceuticals/ArticleStandard/Article/detail/603282?ref=25 I started my career as a medical liaison. It was a wonderful opportunity to shape how companies and physicians further scientific understanding of difficult medical problems, focus on key research questions, and address unmet patient needs. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603282null XML http://pharmexec.findpharma.com/pharmexec/Julia-Walker-Astrazeneca/ArticleStandard/Article/detail/603285?ref=25 I started out as a cardiovascular primary care sales rep with Merck in the UK. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603285null XML http://pharmexec.findpharma.com/pharmexec/Joe-Mclane-Merck/ArticleStandard/Article/detail/603300?ref=25 I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603300null XML http://pharmexec.findpharma.com/pharmexec/June-TOC-Supplement/ArticleStandard/Article/detail/605710?ref=25 June Supplement TOC 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/262009/605710null XML http://pharmexec.findpharma.com/pharmexec/Europe/Elan-in-talks-to-sell-stake-to-Bristol/ArticleStandard/Article/detail/600889?ref=25 1 June 2009 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/600889null HTML http://pharmexec.findpharma.com/pharmexec/Noteworthy/Stealth-Pharmas/ArticleStandard/Article/detail/603289?ref=25 The third annual audit reveals how pharma's "other half" performs. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603289/PE0609_stealth_thumbnail.jpg http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603289null XML http://pharmexec.findpharma.com/pharmexec/Marketing/On-the-Right-Pathways/ArticleStandard/Article/detail/603270?ref=25 With staggering year-over-year growth, biosimilars are "the future of medicine." Marketers must position their companies for the inevitable changes. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603270null XML http://pharmexec.findpharma.com/pharmexec/Jeffrey-Tong-Infinity-Pharmaceuticals/ArticleStandard/Article/detail/603272?ref=25 My first introductions to medically relevant biology and chemistry began when I worked with Harvard professor Greg Verdine to figure out how enzymes recognized and repaired damaged DNA. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603272null XML http://pharmexec.findpharma.com/pharmexec/Blair-Jackson-Alkermes/ArticleStandard/Article/detail/603295?ref=25 When Pfizer discontinued Exubera, its disastrously unsuccessful inhaled insulin, in 2007, the soul searching wasn't limited to Manhattan's East 42nd Street. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603295null XML http://pharmexec.findpharma.com/pharmexec/Leadership+Column/Domestic-Intervention/ArticleStandard/Article/detail/603274?ref=25 The United States needs a new focus on educating its future labor force; and it needs parents to take the main role. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603274null XML http://pharmexec.findpharma.com/pharmexec/Marketing/Learning-to-Relate/ArticleStandard/Article/detail/603296?ref=25 A multi-phase implementation strategy can debunk the myth that social media won't work for pharma. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603296null XML http://pharmexec.findpharma.com/pharmexec/Noteworthy/Pay-For-Play/ArticleStandard/Article/detail/603303?ref=25 The P4P movement is here. Pharma marketers, it's time to take note. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603303/PE0609_P4P_thumbnail.jpg http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603303null XML http://pharmexec.findpharma.com/pharmexec/Carrolee-Barlow-Braincells-Inc/ArticleStandard/Article/detail/603278?ref=25 If Carrolee Barlow has her way, the next new class of antidepressants will be branded BCI for BrainCells, Inc., the hot young San Diego biopharma riding the wave of neurogenesis. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603278null XML http://pharmexec.findpharma.com/pharmexec/Andrew-Cheng-Gilead-Sciences/ArticleStandard/Article/detail/603271?ref=25 Gilead toasted Andrew Cheng's decade as a kingpin in its HIV franchise with a new promotion in February to a custom-made job. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603271null XML http://pharmexec.findpharma.com/pharmexec/Scott-Cormack-Oncogenex-Pharmaceuticals/ArticleStandard/Article/detail/603290?ref=25 I began my career with an interest in medicine and pharmaceutical sciences. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603290null XML http://pharmexec.findpharma.com/pharmexec/Michelle-Dipp-GlaxoSmithKline/ArticleStandard/Article/detail/603292?ref=25 It's hard to believe that Michelle Dipp has been in the industry for only five years considering her significant impact thus far on it. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603292null XML http://pharmexec.findpharma.com/pharmexec/Jason-Rhodes-Alnylam/ArticleStandard/Article/detail/603293?ref=25 I've always loved the life sciences, and have been fortunate to have my career take place during a time of profound advances in biology. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603293null XML http://pharmexec.findpharma.com/pharmexec/Kathryn-Metcalfe-Pfizer/ArticleStandard/Article/detail/603299?ref=25 I trained as a journalist and worked at news organizations where all the reporters wanted to cover politics and crime. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603299null XML http://pharmexec.findpharma.com/pharmexec/Europe/AstraZeneca-and-Merck-form-collaboration/ArticleStandard/Article/detail/600890?ref=25 1 June 2009 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/232009/600890null HTML http://pharmexec.findpharma.com/pharmexec/From+the+Editor/High-School-Justice/ArticleStandard/Article/detail/603301?ref=25 FDA slaps down Cheerios and forces pharma companies that use Google to make technical changes no consumer will ever notice. Big whoop. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603301null XML http://pharmexec.findpharma.com/pharmexec/Ceci-Zak-Sanofi-Aventis-US/ArticleStandard/Article/detail/603284?ref=25 The catalyst for innovation in the current environment is that people are living longer and the industry is not equipped to handle the significant burden that will place on the system. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603284null XML http://pharmexec.findpharma.com/pharmexec/Craig-Dashefsky-Schering-Plough/ArticleStandard/Article/detail/603286?ref=25 I have had the tremendous good fortune of strong leadership throughout my career. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603286null XML http://pharmexec.findpharma.com/pharmexec/Stefan-Platz-Roche/ArticleStandard/Article/detail/603287?ref=25 I started off as a pathologist at Boehringer-Ingelheim in Germany. 2009-06-01T04:00:00Z http://pharmexec.findpharma.com/pharmexec/data/articlestandard/pharmexec/242009/603287null XML